Zeke Capital Advisors, LLC Haemonetics Corp Transaction History

Zeke Capital Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 24, 2020	SELL	$74.34 - $121.82 $395,934 - $648,813	-5,326 Closed	0 $0
Q3 2019 Oct 18, 2019	SELL	$117.16 - $138.52 $51,198 - $60,533	-437 Reduced 7.58%	5,326 $672,000
Q1 2019 Apr 29, 2019	SELL	$83.25 - $102.12 $486,762 - $597,095	-5,847 Reduced 50.36%	5,763 $504,000
Q4 2018 Feb 11, 2019	BUY	$90.66 - $116.63 $467,714 - $601,694	5,159 Added 79.97%	11,610 $1.16 Million
Q3 2018 Nov 08, 2018	BUY	$89.96 - $114.58 $335,280 - $427,039	3,727 Added 136.82%	6,451 $739,000
Q2 2018 Jul 24, 2018	BUY	$71.53 - $95.75 $194,847 - $260,823	2,724 New	2,724 $244,000

332

53.8M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.87B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Zeke Capital Advisors, LLC with notifications on news.